Avacta Group Plc (AIM:AVCT)
79.00
+1.00 (1.28%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | NaN - NaN |
|---|---|---|---|---|---|---|
| Therapeutics | 113.00K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Therapeutics Growth | -94.50% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Animal Health | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Animal Health Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | NaN - NaN |
|---|---|---|---|---|---|---|
| South Korea | 113.00K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea Growth | -94.50% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United Kingdom | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United Kingdom Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| France | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| France Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of Europe | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of Europe Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of World | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of World Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|